Apply to trial NCT06108076

A few quick questions so the study team can decide if you might be a fit.

RecruitingEarly Phase 1Drug trial

Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes

This study will provide insight into whether cardiac function changes with oral Ketone Esters (KE) administered to patients with Type 2 Diabetes Mellitus (T2DM) and Heart failure with reduced ejection fraction (HFrEF). Plasma ketones are avidly extracted by cardiac muscle and their uptake is not dependent upon insulin or influenced by insulin resistance.

How this works

Answer a few questions
About 5 to 10 minutes. Skip-friendly where possible.
We connect you with the study team
When a site picks up your application, we introduce you to their team directly — with you on the thread.
The team reaches out to schedule screening
Usually within a few business days, via the contact you give.

EmailWe save your progress under this email and copy you when we connect you with the study team.

I agree that Hipa.ai may share my application — my name, contact details, and my answers, including health information — with the official study team for this trial so they can review my responses and contact me.

By continuing, you agree to our terms of service.

Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes

How this works

Answer a few questions

We connect you with the study team

The team reaches out to schedule screening